For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Microbiome Drug as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other
Types Segment:
- Probiotics
- Prebiotics
- Small Molecules
- Biological Drugs
- Other
Companies Covered:
- Pfizer
- Second Genome
- Seres Therapeutics
- MaaT Pharma
- Enterome Bioscience
- MicroBiome Therapeutics
- Ritter Pharmaceuticals
- Rebiotix
- OpenBiome
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Pfizer
- Second Genome
- Seres Therapeutics
- MaaT Pharma
- Enterome Bioscience
- MicroBiome Therapeutics
- Ritter Pharmaceuticals
- Rebiotix
- OpenBiome